Leukemia, Myelomonocytic, Juvenile
Showing 51 - 75 of 5,947
Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))
Completed
- Chronic Myelomonocytic Leukemia
- +4 more
- Imatinib Mesylate (Gleevec)
-
Houston, TexasUT MD Anderson Cancer Center
Dec 7, 2021
Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,
Completed
- Myelodysplastic Syndrome
- +13 more
- Fludarabine
- +4 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 2, 2022
Azacitidine in International Prognostic Scoring System
Recruiting
- Myelodysplastic Syndromes
- +2 more
-
Hefei, Anhui, China
- +16 more
Sep 6, 2022
Acute Myeloid Leukaemia; MDS;Chronic Myelomonocytic Leukemia Trial in Shenzhen (Azacytidine, HAG Regimen, Azacytidine)
Recruiting
- Acute Myeloid Leukaemia; Myelodysplastic Syndromes;Chronic Myelomonocytic Leukemia
- Azacytidine, HAG Regimen
- Azacytidine
-
Shenzhen, Guangdong, ChinaShenzhen Second People's Hospital
Mar 14, 2022
Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myeloproliferative Tumor Trial in Houston (Azacitidine, Quizartinib)
Recruiting
- Chronic Myelomonocytic Leukemia
- +5 more
-
Houston, TexasM D Anderson Cancer Center
May 23, 2022
Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Birmingham (NTX-301)
Recruiting
- Acute Myeloid Leukemia
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 6, 2021
MDS, Chronic Myelomonocytic Leukemia, Stem Cell Leukemia Trial in Boston (Inqovi)
Recruiting
- Myelodysplastic Syndromes
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 29, 2021
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, High Risk
Recruiting
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +5 more
- Gemtuzumab Ozogamicin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) Trial in Huddinge, Uppsala (NEX-18a injection,
Terminated
- Myelodysplastic Syndromes (MDS)
- +2 more
- NEX-18a injection
- Azacitidine Injection
-
Huddinge, Sweden
- +1 more
Apr 4, 2022
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)
Active, not recruiting
- Leukemia
- +7 more
- Decitabine
- +3 more
-
Boston, Massachusetts
- +10 more
Jan 19, 2023
FLT3 Gene Mutation Negative, FLT3 Internal Tandem Duplication Positive, Recurrent Acute Myeloid Leukemia Trial in Houston
Active, not recruiting
- FLT3 Gene Mutation Negative
- +7 more
- Azacitidine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2022
Acute Leukemia, Acute Myeloid Leukemia, MDS Trial in Philadelphia (CliniMACS Cell Processing System for TCRaß + T Cell and
Recruiting
- Acute Leukemia
- +7 more
- CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 21, 2022
Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +6 more
- clofarabine
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Severe/Moderate Coronavirus, Chronic Myelomonocytic Leukemia, MDS Trial in Villejuif (Blood samples)
Not yet recruiting
- Severe/Moderate Coronavirus
- +3 more
- Blood samples
-
Villejuif, FranceGustave Roussy Institut
Dec 20, 2021
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells Trial in
Recruiting
- Acute Myeloid Leukemia
- +7 more
- Azacitidine
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
May 16, 2022
Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome Trial in United
Completed
- Chronic Myelomonocytic Leukemia
- +4 more
-
Los Angeles, California
- +4 more
Oct 5, 2022
Myelodysplastic Syndrome, Myeloproliferative Tumors, Chronic Myelomonocytic Leukemia Trial in United States (other, drug,
Recruiting
- Myelodysplastic Syndrome
- +4 more
- Geriatric assessment (GA) pre-transplant
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Aug 24, 2022
Refractory Chronic Myelomonocytic Leukemia, Refractory Myelodysplastic Syndrome Trial in Houston (Fostamatinib)
Recruiting
- Refractory Chronic Myelomonocytic Leukemia
- Refractory Myelodysplastic Syndrome
-
Houston, TexasM D Anderson Cancer Center
Aug 31, 2021
MDS, Chronic Myelomonocytic Leukemia (CMML) Trial (SNS-301)
Withdrawn
- Myelodysplastic Syndromes
- Chronic Myelomonocytic Leukemia (CMML)
- (no location specified)
Aug 9, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +15 more
- Laboratory Biomarker Analysis
- +3 more
-
Chicago, Illinois
- +2 more
Jan 12, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)
Recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Cyclophosphamide
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Philadelphia (procedure, drug, radiation)
Recruiting
- Acute Lymphoblastic Leukemia
- +15 more
- Hematopoietic Cell Transplantation
- +7 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Apr 1, 2022